Free Trial

SurgePays (SURG) Stock Forecast & Price Target

SurgePays logo
$2.47 +0.22 (+9.78%)
As of 04/14/2025 04:00 PM Eastern

SurgePays - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
0
Buy
1

Based on 1 Wall Street analysts who have issued ratings for SurgePays in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for SURG.

Consensus Price Target

$8.50
244.13% Upside
According to the 1 analysts' twelve-month price targets for SurgePays, the average price target is $8.50. The highest price target for SURG is $8.50, while the lowest price target for SURG is $8.50. The average price target represents a forecasted upside of 244.13% from the current price of $2.47.
Get the Latest News and Ratings for SURG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for SurgePays and its competitors.

Sign Up

SURG Analyst Ratings Over Time

TypeCurrent Forecast
4/15/24 to 4/15/25
1 Month Ago
3/16/24 to 3/16/25
3 Months Ago
1/16/24 to 1/15/25
1 Year Ago
4/16/23 to 4/15/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$8.50$8.50$8.50$10.00
Forecasted Upside244.13% Upside620.34% Upside405.95% Upside167.38% Upside
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy
Remove Ads

SURG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SURG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

SurgePays Stock vs. The Competition

TypeSurgePaysComputer and Technology CompaniesS&P 500
Consensus Rating Score
3.00
2.67
2.54
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside244.13% Upside146.30% Upside25.85% Upside
News Sentiment Rating
Positive News

See Recent SURG News
Positive News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/16/2024Ascendiant Capital Markets
2 of 5 stars
 Lower TargetBuy ➝ Buy$9.00 ➝ $8.50+377.53%
3/13/2024Maxim Group
3 of 5 stars
 DowngradeBuy ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 03:22 AM ET.


Should I Buy SurgePays Stock? SURG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 4, 2025. Please send any questions or comments about these SurgePays pros and cons to contact@marketbeat.com.

SurgePays
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in SurgePays, Inc.:

  • SurgePays, Inc. operates in the growing financial technology and telecom sectors, which are increasingly essential in today's digital economy, providing a strong foundation for future growth.
  • The company has diversified its offerings across three segments, including Mobile Virtual Network Operators and Comprehensive Platform Services, which can help mitigate risks associated with reliance on a single revenue stream.
  • Recent estimates from analysts suggest a potential earnings per share (EPS) of $0.19 for Q1 2026, indicating a positive outlook for the company's financial performance in the near term.
  • As of now, the stock price of SurgePays, Inc. is positioned attractively for investors looking for opportunities in the telecom and fintech markets, especially given the company's innovative service offerings.
  • SurgePays, Inc. has established partnerships with convenience stores for fintech transactions, which could enhance its market reach and customer base, driving revenue growth.

SurgePays
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in SurgePays, Inc. for these reasons:

  • Analysts have recently reduced their Q4 2025 EPS estimates from $0.11 to $0.06, indicating potential challenges in meeting financial expectations.
  • The consensus estimate for the current full-year earnings is projected at ($1.66) per share, suggesting that the company may face significant losses, which could deter potential investors.
  • SurgePays, Inc. operates in a highly competitive market, which may impact its ability to maintain or grow its market share against larger, more established companies.
  • The reliance on lead generation and case management solutions primarily for law firms in the mass tort industry may expose SurgePays, Inc. to sector-specific risks and fluctuations.
  • Market volatility and economic uncertainties could adversely affect SurgePays, Inc.'s performance, making it a riskier investment in the current climate.

SURG Forecast - Frequently Asked Questions

According to the research reports of 1 Wall Street equities research analysts, the average twelve-month stock price forecast for SurgePays is $8.50, with a high forecast of $8.50 and a low forecast of $8.50.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SurgePays in the last twelve months. There is currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" SURG shares.

According to analysts, SurgePays's stock has a predicted upside of 244.13% based on their 12-month stock forecasts.

Analysts like SurgePays more than other "computer and technology" companies. The consensus rating for SurgePays is Buy while the average consensus rating for "computer and technology" companies is Moderate Buy. Learn more on how SURG compares to other companies.


This page (NASDAQ:SURG) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners